92 Years of Payouts, Dividend Aristocrat Status, and a 10-Year Decline. The End of a Dividend Legend
For ninety-two consecutive years it paid a dividend, increased it almost fifty years in a row, and ranked among the elite dividend aristocrats of the S&P 500 index. As recently as 2015, its stock traded above $97, and the company operated over 8,000 drugstores across the United States – a synonym for conservative, dull reliability for millions of retail investors. Yet in ten years the stock lost nearly ninety percent of its value, the company first cut its dividend in half and then eliminated it entirely, and finally it vanished from the stock exchange after being bought by a private equity fund. Walgreens Boots Alliance today no longer exists as a publicly traded company, as if it had been a loss-making enterprise on the brink of bankruptcy from the start, not a dividend aristocrat whose stock was among the safest bets on the market just a decade ago.

Key points
The dividend fell in two waves: by 48% in January 2024 and completely in January 2025, ending a payout streak that stretched back to 1933.
Between January 2024 and January 2025, the stock lost roughly four-fifths of its value, from just under $53 to $11–$13 per share.
A more than $6 billion investment in VillageMD ended with a $5.8 billion goodwill write-down and the piecemeal sale of clinics.
The cash position dropped 73% between August 2024 and May 2025, from $3.1 billion to $830 million, mainly due to debt repayments and lawsuits.
In August 2025, the company was acquired by Sycamore Partners for $11.45 per share and delisted, while the British Boots is emerging as probably the most valuable part of the former conglomerate.
Back in 2015, Walgreens Boots Alliance’s stock price exceeded $97, and the company was considered one of the most reliable dividend payers in the US market, with an almost fifty-year history of payout growth. A decade later, the retail chain was bought by private equity firm Sycamore Partners for $11.45 per share – about 88 percent lower. The dividend was completely scrapped, and the company disappeared from the stock exchange.
Walgreens’ collapse ranks among the most dramatic value destructions in the history of American retail. It shows how a conservative, seemingly dull company can turn into a cautionary tale of poor capital allocation, structural industry-wide pressure, and management decisions that together destroyed tens of billions of dollars within a single decade. That is precisely why Walgreens’ case is worth examining in detail, even though the stock is no longer directly investable. The lessons it offers can be applied to a whole range of other companies in defensive sectors that look safe – until their business model starts to decay from the inside.
The Fall of a Dividend Aristocrat
Walgreens paid shareholders a dividend for 92 consecutive years and had raised it without interruption since the mid-1970s, placing it among the elite group of so-called dividend aristocrats – companies in the S&P 500 with at least twenty-five consecutive years of payout growth. In January 2024, that era ended. The board cut the quarterly dividend from $0.48 to $0.25 per share, a 48 percent reduction, and the company was subsequently removed from the dividend aristocrat index. A year later came the second pivotal turn: in January 2025, Walgreens announced a complete suspension of the dividend, ending the payout streak dating back to 1933.
Finish the whole article on AMZN
And you also unlock fair value and more tools
Black membership: analyses, screener, newsletters and unlimited StockBot.